Clinical characteristics, temporal trends, and predictors of liver transplantation-free survival in patients with autoimmune hepatitis: a nationwide Japanese registry study.
Abe Kazumichi K, Ohira Hiromasa H, Takahashi Atsushi A, Hayashi Manabu M et al.
Complete biochemical response (CBR) is a key therapeutic target in autoimmune hepatitis (AIH), but nationwide Japanese data linking treatment response, temporal changes in practice, and liver transplantation (LT)-free survival remain limited. We evaluated clinical characteristics, diagnostic period trends, and predictors of LT-free survival using the Japanese Autoimmune Hepatitis Study Group registry. Patients newly diagnosed with AIH between 1998 and 2024 were screened. Baseline diagnostic data were available for 3992 patients, and 2494 patients with follow-up data were included in the survival analysis. Landmark analyses were performed at 6 and 12 months after treatment initiation. CBR was defined as the normalization of serum AST, ALT, and IgG levels. LT-free survival was assessed using Kaplan‒Meier analysis and Cox proportional hazards models. Among 3992 patients, 1163 were diagnosed from 2018 onward. Recent patients were older and had a slightly lower female proportion, more frequent cirrhosis at diagnosis, and more frequent azathioprine and ursodeoxycholic acid use. In the survival cohort, the median age was 63 years, 82.6% were female, and 10.8% had cirrhosis. During a median follow-up of 3.2 years, CBR was achieved in 53.5% at the 6-month landmark and 66.9% at the 12-month landmark. The estimated LT-free survival rates were 96.6% at 3 years and 95.8% at 5 years. Older age, male sex, cirrhosis at diagnosis, and a lack of CBR at the 6- or 12-month landmark independently predicted poorer LT-free survival. In liver-specific analyses, cirrhosis at diagnosis and lack of early CBR remained associated with liver-related death or LT. Baseline cirrhosis and failure to achieve early CBR may help identify high-risk AIH patients who require closer monitoring and clinical reassessment.